Carriers of a single CFTR mutation are asymptomatic: an evolving dogma?
- PMID: 32912926
- DOI: 10.1183/13993003.02645-2020
Carriers of a single CFTR mutation are asymptomatic: an evolving dogma?
Conflict of interest statement
Conflict of interest: C. Martin reports personal fees from Vertex and Zambon, outside the submitted work. Conflict of interest: P-R. Burgel reports personal fees for advisory board work and lectures from AstraZeneca, Chiesi, GSK, Novartis, Teva and Vertex, grants and personal fees for advisory board work and lectures from Boehringer Ingelheim, personal fees for advisory board work from Zambon, personal fees for lectures from Pfizer, outside the submitted work.
Comment on
-
Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population.Eur Respir J. 2020 Sep 10;56(3):2000558. doi: 10.1183/13993003.00558-2020. Print 2020 Sep. Eur Respir J. 2020. PMID: 32398304
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical